In order to understand the mechanisms involved in breast cancer in diabetic and obese patients and to look for a potential target therapy, we will investigate whether the hyperinsulinemia state in diabetic or obese patients promotes more frequently GLUT-1 overexpressing cancers. Here, SLC2A1 is linked to cancer.